Navigation Links
Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward

New York, New York (PRWEB) December 30, 2012

Propecia lawsuits alleging use of the drug caused men to suffer persistent sexual side effects continue to move forward in a consolidated litigation now underway in New Jersey Superior Court, Middlesex County. According to court records, 248 claims are pending in the New Jersey Propecia litigation, and the proceeding’s next Status Conference is scheduled for January 10, 2013. (In Re: Propecia Litigation – No. 623, N.J. Sup. Ct.).

“We continue to hear from men who have allegedly suffered persistent sexual dysfunction long after they stopped taking Propecia. We look forward to this litigation, as well as the federal litigation, moving forward in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free lawsuit reviews to alleged victims of Propecia sexual side effects.

Propecia Sexual Side Effects
Propecia is a prescription medicine that is used to treat male pattern baldness that has recently been linked to sexual dysfunction in men. In April 2012, the U.S. Food & Drug Administration (FDA) announced that the Propecia label would be updated to advise that some men had experienced persistent sexual dysfunction, including problems with libido, ejaculation and orgasm, long after their use of the drug had ended.*

Since the FDA announcement, additional research has confirmed an association between Propecia and male sexual dysfunction. For example, a July 2012 study in the Journal of Sexual Medicine found that such problems may last months after patients stop using the drug.** A survey of men who suffered Propecia sexual side effects published in the Journal of Clinical Psychiatry in August 2012 found that 75 percent reported symptoms of depression. Forty-four percent reported suicidal thoughts.***

In addition to the New Jersey litigation, a federal multidistrict litigation has been established for federally filed Propecia lawsuits in the U.S. District Court, Eastern District of New York (Propecia (Finasteride) Product Liability Litigation – MDL No. 2331).

Victims of Propecia sexual side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. For more information about filing a Propecia sexual dysfunction lawsuit, please visit Bernstein Liebhard LLP’s website, or call (877) 779-1414 to speak with one of our attorneys today.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Lawsuit on Propecia: Severe Adverse Events
2. Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
3. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
4. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
5. DrugRisk Announces Updated Information on Mirena Lawsuits
6. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
7. Dr. Farshchian: Subacromion Bursitis is Now being Treated with Cell Therapy
8. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
9. Dr. Farshchian: Rotator Cuff Injuries are being Treated Now Using Cell Therapy at the Center for Regenerative Medicine
10. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
11. TMAIDA PR Announces that CHEW Owner, a Chicago Wellness Company is Being Recognized as a "Diva" by Chicago Publicist/Socialite Owner of Maven Chicago
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
Breaking Medicine Technology: